David Masson

Summary

Country: France

Publications

  1. pmc Increased HDL cholesterol and apoA-I in humans and mice treated with a novel SR-BI inhibitor
    David Masson
    Division of Molecular Medicine, Department of Medicine, Columbia University, New York, USA
    Arterioscler Thromb Vasc Biol 29:2054-60. 2009
  2. pmc Reduced VLDL clearance in Apoe(-/-)Npc1(-/-) mice is associated with increased Pcsk9 and Idol expression and decreased hepatic LDL-receptor levels
    Minako Ishibashi
    Division of Molecular Medicine, Department of Medicine, Columbia University, New York, NY, USA
    J Lipid Res 51:2655-63. 2010

Detail Information

Publications2

  1. pmc Increased HDL cholesterol and apoA-I in humans and mice treated with a novel SR-BI inhibitor
    David Masson
    Division of Molecular Medicine, Department of Medicine, Columbia University, New York, USA
    Arterioscler Thromb Vasc Biol 29:2054-60. 2009
    ..Increasing HDL levels is a potential strategy for the treatment of atherosclerosis...
  2. pmc Reduced VLDL clearance in Apoe(-/-)Npc1(-/-) mice is associated with increased Pcsk9 and Idol expression and decreased hepatic LDL-receptor levels
    Minako Ishibashi
    Division of Molecular Medicine, Department of Medicine, Columbia University, New York, NY, USA
    J Lipid Res 51:2655-63. 2010
    ..In contrast to modest induction of hepatic IDOL with synthetic LXR ligands, a striking upregulation of IDOL in Apoe(-/-)Npc1(-/-) mice could indicate a role of endogenous LXR ligands in regulation of hepatic IDOL...